المنشور

07:51 AM EST, 11/12/2026 (MT Newswires) -- Twist Bioscience (TWST) reported a fiscal Q4 net loss of $ 0.32 per share on Thursday, narrowing from a loss of $0.45 a year earlier. Analysts surveyed by FactSet expected a loss of $0.39 per share. Revenue for the fiscal quarter ended Sept. 30 was $126.6 million, up from $99 million a year earlier. Analysts expected $123.5 million. For fiscal Q1, the company expects revenue of $130 million to $132 million. Analysts expect $126.4 million. Twist Bioscience also expects fiscal 2027 revenue of $550 million to $560 million. Analysts expect $548.6 million. Shares of the company were down 7.8% in Thursday premarket activity.